Search results
Q1 2024 Omeros Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance Canada· 2 months agoParticipants Jennifer Cook-Williams; Investor and Media Relations; Cook Williams Communications, Inc. Gregory Demopulos; Chairman of the Board, President, Chief Executive Officer; Omeros Corp ...
Lumos Pharma Inc (LUMO) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial ...
GuruFocus.com via Yahoo Finance Canada· 2 months agoCash and Cash Equivalents: $23.2 million as of March 31, 2024. Research and Development Expenses: $7.2 million for Q1 2024, up $2.9 million year-over-year. General and Administrative Expenses ...
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 2 months agoRelmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call Transcript May 10, 2024 Relmada...
Intellia Therapeutics Q1 2024 Earnings: Aligns with Analyst Projections Amidst Strategic Advances
GuruFocus.com via Yahoo Finance Canada· 3 months agoRevenue: Reported $28.9 million in collaboration revenue for Q1 2024, surpassing the estimated $19.18 million. Net Loss: Recorded a net loss of $107.4 million, below the estimated net loss of ...
Bumble Inc. (NASDAQ:BMBL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 3 months agoBumble Inc. (NASDAQ:BMBL) Q1 2024 Earnings Call Transcript May 8, 2024 Bumble Inc. isn’t one of the...
Q1 2024 Y-mAbs Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance Canada· 3 months agoParticipants Courtney Dugan; VP & Head of IR; Y-mAbs Therapeutics Inc Michael Rossi; President, Chief Executive Officer, Director; Y-mAbs Therapeutics Inc Susan Smith; Senior Vice President, ...
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Zacks via Yahoo Finance Canada· 4 months agoPipeline and regulatory updates continue to be in focus in the biotech sector. While nothing much...
Q4 2023 OmniAb Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance Canada· 4 months agoParticipants Kurt A. Gustafson; Executive VP of Finance & CFO; OmniAb, Inc. Matthew W. Foehr; President, CEO & Director; OmniAb, Inc. Alexander Xenakis Chad M. Wiatrowski; Associate; TD Cowen ...
Tyra Biosciences Inc (TYRA) Reports Increased R&D Investments Amid Pipeline Progress
GuruFocus.com via Yahoo Finance Canada· 4 months agoNet Loss: Q4 net loss widened to $22.8 million from $12.9 million in the same period last year. Research and Development Expenses: R&D expenses increased to $20.7 million in Q4, up from $10.4 ...
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 4 months agoAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2023 Earnings Call Transcript March 18, 2024 Alpine...
